Valproic acid inhibits proliferation of EB virus-infected natural killer cells (Q39337509)

11 September 2017

Valproic acid inhibits proliferation of EB virus-infected natural killer cells (English)

1 reference

11 September 2017

Kazuyasu Fujii

1

1 reference

11 September 2017

Norihiro Suzuki

2

1 reference

11 September 2017

Takenobu Yamamoto

3

1 reference

11 September 2017

Daisuke Suzuki

4

1 reference

11 September 2017

Keiji Iwatsuki

5

1 reference

11 September 2017

1 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

17

1 reference

11 September 2017

3

1 reference

11 September 2017

163-169

1 reference

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

11 September 2017

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Chronic, symptomatic Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

The chronic mononucleosis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Histone Deacetylase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Production of proinflammatory cytokines without invocation of cytotoxic effects by an Epstein-Barr virus-infected natural killer cell line established from a patient with hypersensitivity to mosquito bites

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid for the treatment of myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid for the treatment of myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid inhibits angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Treatment approaches for acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Bone marrow suppression induced by high dose valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453312X13376952196494

10.1179/102453312X13376952196494

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference